Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 113,857 |
|
|||||
| News | - | ||||||
| Day High | 9.335 | Low High |
|||||
| Day Low | 8.66 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Solid Biosciences Inc | SLDB | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.56 | -6.05% | 8.70 | 17:57:44 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 9.13 | 8.66 | 9.335 | 8.70 | 9.26 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,370 | 113,857 | $ 8.94 | $ 1,017,727 | - | 1.81 - 15.05 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:01 | 9 | $ 8.70 | USD |
Solid Biosciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 330M | 37.76M | - | 0 | -96.02M | -2.54 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Solid Biosciences News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SLDB Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 10.75 | 10.841 | 8.66 | 9.91 | 165,242 | -2.05 | -19.07% |
| 1 Month | 13.39 | 15.05 | 8.66 | 12.31 | 239,706 | -4.69 | -35.03% |
| 3 Months | 8.15 | 15.05 | 5.40 | 10.85 | 269,823 | 0.55 | 6.75% |
| 6 Months | 2.18 | 15.05 | 1.81 | 6.42 | 453,534 | 6.52 | 299.08% |
| 1 Year | 4.90 | 15.05 | 1.81 | 6.34 | 236,387 | 3.80 | 77.55% |
| 3 Years | 74.25 | 81.90 | 1.81 | 26.03 | 552,561 | -65.55 | -88.28% |
| 5 Years | 138.15 | 203.70 | 1.81 | 55.24 | 846,762 | -129.45 | -93.70% |
Solid Biosciences Description
| Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of speciality and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. Its lead product candidate, the SGT-001, is a gene transfer under development to restore functional dystrophin protein expression in patients' muscles. The company's pipeline products are the SB-001 and solid suit. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices. |
